Human medicines European public assessment report (EPAR): Pazenir, paclitaxel, Date of authorisation: 06/05/2019, Revision: 10, Status: Authorised

Herbal medicinal product: Zingiberis rhizoma, Zingiber officinale Roscoe, F: Assessment finalised

Human medicines European public assessment report (EPAR): Lupkynis, voclosporin, Date of authorisation: 15/09/2022, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Zelboraf, vemurafenib, Date of authorisation: 17/02/2012, Revision: 26, Status: Authorised

Outcome of written procedures finalised during the period from 4 March 2025 to 28 May 2025

Human medicines European public assessment report (EPAR): Jetrea, ocriplasmin, Date of authorisation: 13/03/2013, Revision: 15, Status: Withdrawn

Human medicines European public assessment report (EPAR): Aquipta, atogepant, Date of authorisation: 11/08/2023, Revision: 4, Status: Authorised

New product information wording: extracts from PRAC recommendations on signals adopted at the 7-10 April 2025 PRAC

How we work

Code of conduct of the European Medicines Agency